AU Patent

AU2018374850A1 — Method for reducing ototoxicity in pediatric patients receiving platinum-based chemotherapy

Assigned to Oregon Health and Science University · Expires 2020-07-02 · 6y expired

What this patent protects

Described herein is a method for eliminating or reducing ototoxicity in patients receiving a platinum based chemotherapeutic. In particular, are methods of reducing ototoxicity in a pediatric patient. The methods described herein include administering an effective amount of sodiu…

USPTO Abstract

Described herein is a method for eliminating or reducing ototoxicity in patients receiving a platinum based chemotherapeutic. In particular, are methods of reducing ototoxicity in a pediatric patient. The methods described herein include administering an effective amount of sodium thiosulfate to a patient in need thereof to reduce ototoxicity.

Drugs covered by this patent

Patent Metadata

Patent number
AU2018374850A1
Jurisdiction
AU
Classification
—
Expires
2020-07-02
Drug substance claim
No
Drug product claim
No
Assignee
Oregon Health and Science University
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.